CARBOGEN AMCIS

CARBOGEN AMCIS Contract Manufacturing & Development (CDMO) Profile

CARBOGEN AMCIS provides drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) – as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products produced at our facility in The Netherlands. These products are used in a variety of markets around the globe.

Our focus is to help customers create a better world by becoming the partner of choice for development and manufacture. The guiding principles for our service are our passion for great science supported by timely communication and backed by our total commitment to YOUR project.

We forge close collaboration and open communication with our customers which ensures we work effectively as a team, meeting (if not exceeding) our customers’ expectations. We aim to manufacture pharmaceutical ingredients at the highest standard of GMP whilst protecting the environment.

We are a partner you can trust and we look forward to helping you move your project faster to the market!

CDMO Services:
API and/or Ingredients; Finished Dosage Forms (Small Molecule Drugs) Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS) Analytical Development; Formulation Development; ICH Stability Testing; Process Development Antibodies; Antibody-drug conjugate (ADC)

Year Founded: 2007

Head Office: Bubendorf, Switzerland

Number of Facilities: 6-10

Facility locations: Europe; China

Website: Visit the CARBOGEN AMCIS website

Linkedin: Connect on Linkedin

Current Capacity: Available capacity 35%